These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15245741)

  • 1. Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs.
    Bailey J; Blankson JN; Wind-Rotolo M; Siliciano RF
    Curr Opin Immunol; 2004 Aug; 16(4):470-6. PubMed ID: 15245741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations.
    Deng K; Pertea M; Rongvaux A; Wang L; Durand CM; Ghiaur G; Lai J; McHugh HL; Hao H; Zhang H; Margolick JB; Gurer C; Murphy AJ; Valenzuela DM; Yancopoulos GD; Deeks SG; Strowig T; Kumar P; Siliciano JD; Salzberg SL; Flavell RA; Shan L; Siliciano RF
    Nature; 2015 Jan; 517(7534):381-5. PubMed ID: 25561180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on inducing efficient immune control of HIV-1 replication--a new goal for HIV therapeutics?
    Bucy RP; Kilby JM
    AIDS; 2001 Feb; 15 Suppl 2():S36-42. PubMed ID: 11424975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1.
    Bertagnolli LN; Varriale J; Sweet S; Brockhurst J; Simonetti FR; White J; Beg S; Lynn K; Mounzer K; Frank I; Tebas P; Bar KJ; Montaner LJ; Siliciano RF; Siliciano JD
    Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32066-32077. PubMed ID: 33239444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latently infected cell activation: a way to reduce the size of the HIV reservoir?
    Forde J; Volpe JM; Ciupe SM
    Bull Math Biol; 2012 Jul; 74(7):1651-72. PubMed ID: 22562387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1.
    Deeks SG; Martin JN; Sinclair E; Harris J; Neilands TB; Maecker HT; Hagos E; Wrin T; Petropoulos CJ; Bredt B; McCune JM
    J Infect Dis; 2004 Jan; 189(2):312-21. PubMed ID: 14722897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infection.
    Wang B; Dyer WB; Zaunders JJ; Mikhail M; Sullivan JS; Williams L; Haddad DN; Harris G; Holt JA; Cooper DA; Miranda-Saksena M; Boadle R; Kelleher AD; Saksena NK
    Virology; 2002 Dec; 304(2):246-64. PubMed ID: 12504566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of immune-modulating compounds to disrupt HIV latency.
    Remoli AL; Marsili G; Battistini A; Sgarbanti M
    Cytokine Growth Factor Rev; 2012; 23(4-5):159-72. PubMed ID: 22766356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.
    Chun TW; Justement JS; Moir S; Hallahan CW; Maenza J; Mullins JI; Collier AC; Corey L; Fauci AS
    J Infect Dis; 2007 Jun; 195(12):1762-4. PubMed ID: 17492591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients.
    Vallejo A; Gutierrez C; Hernandez-Novoa B; Diaz L; Madrid N; Abad-Fernandez M; Dronda F; Perez-Elias MJ; Zamora J; Muñoz E; Muñoz-Fernandez MA; Moreno S
    AIDS; 2012 Sep; 26(15):1885-94. PubMed ID: 22992577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses.
    Markowitz M; Vesanen M; Tenner-Racz K; Cao Y; Binley JM; Talal A; Hurley A; Jin X; Chaudhry MR; Yaman M; Frankel S; Heath-Chiozzi M; Leonard JM; Moore JP; Racz P; Nixon DF; Ho DD
    J Infect Dis; 1999 Mar; 179(3):527-37. PubMed ID: 9952358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of antiretroviral therapy during chronic SIV infection leads to rapid reduction in viral loads and the level of T-cell immune response.
    Boyer JD; Kumar S; Robinson T; Parkinson R; Wu L; Lewis M; Weiner DB
    J Med Primatol; 2006 Aug; 35(4-5):202-9. PubMed ID: 16872283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of sequence evolution at epitopes for host antibodies and cytotoxic T-lymphocytes in human immunodeficiency virus type 1.
    Piontkivska H; Hughes AL
    Virus Res; 2006 Mar; 116(1-2):98-105. PubMed ID: 16214253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immune response to human immunodeficiency virus.
    Norris PJ; Rosenberg ES
    AIDS; 2001 Feb; 15 Suppl 2():S16-21. PubMed ID: 11424972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
    Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution.
    Siliciano RF
    Top HIV Med; 2005; 13(3):96-100. PubMed ID: 16170226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS. Virological mayhem.
    Wain-Hobson S
    Nature; 1995 Jan; 373(6510):102. PubMed ID: 7816085
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistent HIV-1-specific CTL clonal expansion despite high viral burden post in utero HIV-1 infection.
    Brander C; Goulder PJ; Luzuriaga K; Yang OO; Hartman KE; Jones NG; Walker BD; Kalams SA
    J Immunol; 1999 Apr; 162(8):4796-800. PubMed ID: 10202022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.